Registry analysis of 36,148 relapsing-onset cases showed lower annual DMT treatment probability in late-onset versus adult-onset MS (73.7% vs 83.1%; OR 0.57). Use of highly effective DMTs was reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results